Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Rutherford

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Cell Cycle (Georgetown, Tex.)|July 16, 2016
Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomasRossella Marullo, Sarah C Rutherford, John P Leonard, et al.
Seminars in Hematology|June 30, 2024
The Management of older patients with Hodgkin lymphoma: implications of S1826Marshall McKenna, Yun Kyoung Ryu Tiger, Sarah C Rutherford, et al.
British Journal of Haematology|July 6, 2017
Bone marrow biopsies do not impact response assessment for follicular lymphoma patients treated on clinical trialsSarah C Rutherford, Valery Li, Paola Ghione, et al.
Palliative & Supportive Care|September 12, 2025
Prognostic discussions in patients with advanced lymphoma: Characteristics and challengesMeghan McDarby, Jaime Gilliland, Rinchen Dolma, et al.
Journal of Palliative Medicine|October 22, 2019
Illness Understanding and Advance Care Planning in Patients with Advanced LymphomaKelly M Trevino, Sarah C Rutherford, Chrystal Marte, et al.
Palliative & Supportive Care|June 17, 2022
Unmet mental health needs in patients with advanced B-cell lymphomasChrystal Marte, Login S George, Sarah C Rutherford, et al.
Leukemia & Lymphoma|June 3, 2017
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data<sup/>Sarah C Rutherford, Eric N Stewart, Zhengming Chen, et al.
Leukemia & Lymphoma|July 9, 2019
Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretationKah Poh Loh, Andrea Baran, Christina Y Lee, et al.
The Lancet. Haematology|October 11, 2021
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 studySarah C Rutherford, Jeremy S Abramson, Nancy L Bartlett, et al.
Leukemia & Lymphoma|April 10, 2008
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphomaSarah C Rutherford, Biree Andemariam, Shibu M Philips, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|July 16, 2016
Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomasRossella Marullo, Sarah C Rutherford, John P Leonard, et al.
Seminars in Hematology|June 30, 2024
The Management of older patients with Hodgkin lymphoma: implications of S1826Marshall McKenna, Yun Kyoung Ryu Tiger, Sarah C Rutherford, et al.
British Journal of Haematology|July 6, 2017
Bone marrow biopsies do not impact response assessment for follicular lymphoma patients treated on clinical trialsSarah C Rutherford, Valery Li, Paola Ghione, et al.
Palliative & Supportive Care|September 12, 2025
Prognostic discussions in patients with advanced lymphoma: Characteristics and challengesMeghan McDarby, Jaime Gilliland, Rinchen Dolma, et al.
Journal of Palliative Medicine|October 22, 2019
Illness Understanding and Advance Care Planning in Patients with Advanced LymphomaKelly M Trevino, Sarah C Rutherford, Chrystal Marte, et al.
Palliative & Supportive Care|June 17, 2022
Unmet mental health needs in patients with advanced B-cell lymphomasChrystal Marte, Login S George, Sarah C Rutherford, et al.
Leukemia & Lymphoma|June 3, 2017
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data<sup/>Sarah C Rutherford, Eric N Stewart, Zhengming Chen, et al.
Leukemia & Lymphoma|July 9, 2019
Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretationKah Poh Loh, Andrea Baran, Christina Y Lee, et al.
The Lancet. Haematology|October 11, 2021
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 studySarah C Rutherford, Jeremy S Abramson, Nancy L Bartlett, et al.
Leukemia & Lymphoma|April 10, 2008
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphomaSarah C Rutherford, Biree Andemariam, Shibu M Philips, et al.
Pageof 4